{
  "id": "be3b1719f9886080",
  "title": "Phathom Pharmaceuticals Pivots to GI Focus , Targets 2H 2026 Profitability , CEO Says at Guggenheim Summit",
  "description": "20260214T224500Z",
  "content": "",
  "source": "tickerreport.com",
  "source_url": "https://www.tickerreport.com/banking-finance/13347432/phathom-pharmaceuticals-pivots-to-gi-focus-targets-2h-2026-profitability-ceo-says-at-guggenheim-summit.html",
  "published_at": "20260214T224500Z",
  "fetched_at": "2026-02-15T00:30:56.287245+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [],
  "location": "United States",
  "raw_data": {
    "url": "https://www.tickerreport.com/banking-finance/13347432/phathom-pharmaceuticals-pivots-to-gi-focus-targets-2h-2026-profitability-ceo-says-at-guggenheim-summit.html",
    "url_mobile": "",
    "title": "Phathom Pharmaceuticals Pivots to GI Focus , Targets 2H 2026 Profitability , CEO Says at Guggenheim Summit",
    "seendate": "20260214T224500Z",
    "socialimage": "",
    "domain": "tickerreport.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}